Loading...
XSHE
002727
Market cap867mUSD
Jul 09, Last price  
10.05CNY
1D
-2.33%
1Q
-19.98%
Jan 2017
-52.59%
IPO
3.98%
Name

Yixintang Pharmaceutical Group Co Ltd

Chart & Performance

D1W1MN
XSHE:002727 chart
P/E
22.34
P/S
0.34
EPS
0.45
Div Yield, %
4.98%
Shrs. gr., 5y
-0.55%
Rev. gr., 5y
3.51%
Revenues
17.34b
-3.69%
1,455,978,4521,850,165,9422,218,508,2232,842,139,5363,546,662,0614,428,409,9885,321,152,3306,249,335,7157,751,139,4139,176,269,6689,176,269,66810,479,093,10512,656,284,25814,587,401,32414,587,401,32317,431,615,60417,431,615,60417,380,310,85218,000,454,56717,336,241,788
Net income
263m
+130.80%
84,848,843102,945,179134,709,500182,551,399240,853,277297,309,141346,260,369353,377,018422,714,111521,069,744521,069,750603,917,854789,960,234921,583,567921,583,5731,009,996,1571,009,996,161549,441,532114,138,361263,432,456
CFO
1.63b
-5.07%
55,336,029106,897,562101,552,738157,665,390228,224,995176,218,848185,760,455192,632,310391,156,158635,771,681982,923,9591,033,358,9771,791,674,0422,497,100,4782,115,339,4521,720,546,7171,633,400,628
Dividend
Sep 25, 20250.2 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Yixintang Pharmaceutical Group Co., Ltd. is a prominent Chinese enterprise primarily managing an extensive network of pharmacies nationwide. The company's operations also encompass the production and retail of a diverse array of items, including raw medicinal ingredients, traditional Chinese herbal medicines, and various health and dietary supplements. Furthermore, it actively participates in pharmaceutical distribution. By January 31, 2020, its retail footprint spanned 7,205 outlets across numerous provinces and municipalities, such as Yunnan, Guizhou, Guangxi, Sichuan, Shanxi, Chongqing, Tianjin, Shanghai, and Qiong. Complementing its brick-and-mortar presence, Yixintang also conducts online sales. Established in 2000 with its headquarters in Kunming, China, the company adopted its current name, Yixintang Pharmaceutical Group Co., Ltd., in June 2019, having previously been called Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd.
IPO date
Jul 02, 2014
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122022‑002021‑122020‑122019‑122019‑002018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT